Mml Investors Services, LLC Novartis Ag Transaction History

Mml Investors Services, LLC

  • $29 Billion
  • Q4 2024

A detailed history of Mml Investors Services, LLC transactions in Novartis Ag stock. As of the latest transaction made, Mml Investors Services, LLC holds 148,532 shares of NVS stock, worth $17.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
148,532
Previous 129,201 14.96%
Holding current value
$17.2 Million
Previous $14.9 Million 2.74%
% of portfolio
0.05%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$96.78 - $117.18 $1.87 Million - $2.27 Million
19,331 Added 14.96%
148,532 $14.5 Million
Q3 2024

Nov 15, 2024
BUY
$106.13 - $120.89 $1.14 Million - $1.3 Million
10,763 Added 9.09%
129,201 $14.9 Million
Q2 2024

Aug 14, 2024
SELL
$92.57 - $107.37 $94,236 - $109,302
-1,018 Reduced 0.85%
118,438 $12.6 Million
Q1 2024

May 14, 2024
BUY
$95.27 - $108.47 $2.16 Million - $2.46 Million
22,714 Added 23.48%
119,456 $11.6 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $680,952 - $749,365
7,380 Added 8.26%
96,742 $9.77 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $257,476 - $285,743
2,718 Added 3.14%
89,362 $9.1 Million
Q2 2023

Aug 14, 2023
BUY
$92.52 - $104.91 $1.3 Million - $1.48 Million
14,076 Added 19.4%
86,644 $8.74 Million
Q1 2023

May 12, 2023
SELL
$80.03 - $92.81 $464,734 - $538,947
-5,807 Reduced 7.41%
72,568 $6.68 Million
Q4 2022

Feb 13, 2023
BUY
$75.55 - $92.52 $138,029 - $169,034
1,827 Added 2.39%
78,375 $7.11 Million
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $77,743 - $90,924
1,042 Added 1.38%
76,548 $5.82 Million
Q2 2022

Aug 12, 2022
BUY
$80.52 - $93.75 $270,144 - $314,531
3,355 Added 4.65%
75,506 $6.38 Million
Q1 2022

May 13, 2022
BUY
$80.11 - $90.62 $362,738 - $410,327
4,528 Added 6.7%
72,151 $6.33 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $173,506 - $191,859
-2,177 Reduced 3.12%
67,623 $5.92 Million
Q3 2021

Nov 15, 2021
BUY
$81.78 - $95.14 $326,874 - $380,274
3,997 Added 6.07%
69,800 $5.71 Million
Q2 2021

Aug 13, 2021
SELL
$85.24 - $94.15 $106,890 - $118,064
-1,254 Reduced 1.87%
65,803 $6 Million
Q1 2021

May 14, 2021
SELL
$83.5 - $98.47 $100,033 - $117,967
-1,198 Reduced 1.76%
67,057 $5.73 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $262,861 - $317,945
3,367 Added 5.19%
68,255 $6.45 Million
Q3 2020

Nov 13, 2020
BUY
$82.14 - $91.0 $11,581 - $12,831
141 Added 0.22%
64,888 $5.64 Million
Q2 2020

Aug 14, 2020
BUY
$80.93 - $91.1 $381,827 - $429,809
4,718 Added 7.86%
64,747 $5.66 Million
Q1 2020

May 14, 2020
BUY
$70.67 - $99.01 $705,639 - $988,614
9,985 Added 19.95%
60,029 $4.95 Million
Q4 2019

Feb 11, 2020
BUY
$84.35 - $95.37 $508,040 - $574,413
6,023 Added 13.68%
50,044 $4.74 Million
Q3 2019

Nov 14, 2019
SELL
$85.54 - $94.26 $1,796 - $1,979
-21 Reduced 0.05%
44,021 $3.83 Million
Q2 2019

Aug 13, 2019
BUY
$75.4 - $92.8 $337,264 - $415,094
4,473 Added 11.3%
44,042 $4.02 Million
Q1 2019

May 10, 2019
BUY
$75.32 - $86.15 $270,323 - $309,192
3,589 Added 9.97%
39,569 $3.8 Million
Q4 2018

Feb 14, 2019
BUY
$73.66 - $82.02 $367,268 - $408,951
4,986 Added 16.09%
35,980 $3.09 Million
Q3 2018

Nov 07, 2018
BUY
$66.94 - $77.43 $485,984 - $562,141
7,260 Added 30.59%
30,994 $2.67 Million
Q2 2018

Aug 13, 2018
BUY
$64.91 - $73.36 $176,814 - $199,832
2,724 Added 12.97%
23,734 $1.79 Million
Q1 2018

May 11, 2018
BUY
$70.39 - $84.15 $271,212 - $324,229
3,853 Added 22.46%
21,010 $1.7 Million
Q4 2017

Feb 13, 2018
SELL
$72.33 - $77.64 $372,282 - $399,613
-5,147 Reduced 23.08%
17,157 $1.44 Million
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $1.65 Million - $1.72 Million
22,304
22,304 $1.92 Million

Others Institutions Holding NVS

# of Institutions
1,479
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email